Prognostic impact of immune-related adverse events on survival outcomes in metastatic gastrointestinal cancer: A single-institutional experience. This is an ASCO Meeting Abstract from the 2023 ASCO ...
New research by scientists at Cleveland Clinic demonstrates that pathogenic polymerase epsilon and delta (POLE/POLD1) genetic mutations lead to improved response to immune checkpoint blockade. The ...
New research shows that pathogenic polymerase epsilon and delta (POLE/POLD1) genetic mutations lead to improved response to immune checkpoint blockade, a powerful class of immunotherapy drugs. The ...
Colorectal cancers harbouring mutations in the exonuclease domains of DNA polymerases ε (POLE) and δ (POLD1) exhibit an ‘ultramutated’ phenotype characterised by exceptionally high numbers of somatic ...
Relationship Between Male Pattern Baldness and the Risk of Aggressive Prostate Cancer: An Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Overall mutations (pathogenic, ...
New research from a collaborative team at Cleveland Clinic, led by Timothy Chan, MD, Ph.D., Chair of the Center for Immunotherapy and Precision Immuno-Oncology in the Lerner Research Institute, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results